Shenogen Pharma Group
PrivateLast Round
Series E
Extension
Sep 27, 2023
Total Funding Raised
$45.04M
Company Overview
Shenogen Pharma Group is a biopharmaceutical company that develops and commercializes first-in-class therapeutics for cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shenogen Pharma Group Comparables
Compare Shenogen Pharma Group with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| InnoCare Pharma Limited | 77% | |
| Evopoint Biosciences | 76% | |
| Zai Lab Limited | 74% |
Shenogen Pharma Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E Extension | Sep 27, 2023 | ||||
| Strategic | Sep 1, 2019 | ||||
| Series C Extension | Apr 1, 2019 | ||||
| Series C Extension | Jan 1, 2019 | ||||
| Series C Extension | Jul 21, 2017 | ||||
Series B Extension | Dec 1, 2016 |
Shenogen Pharma Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boxin Capital | Strategic |
| Beijing Jinhuitong Investment Management Co., Ltd. | Strategic |
| IDG Capital | Series B, Series C |
| Zhongzhi Capital | Series C Extension |
| 和灵资本 | Series C Extension |
| Richlink Capital | Series B Extension |
| RCI Capital Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 27, 2023
Raised Series E Extension round with Shenzhen New Henglida Capital Management.
- Apr 1, 2019
Raised Series C Extension round with Zhongzhi Capital.
Shenogen Pharma Group Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shenogen Pharma Group's valuation, stock price, and market status.
Is Shenogen Pharma Group a public or private company?
Shenogen Pharma Group is a private company.
What is the current stock price of Shenogen Pharma Group?
Shenogen Pharma Group is a private company with no public stock price. Caplight tracks Shenogen Pharma Group's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Shenogen Pharma Group worth (valuation)?
Valuation information for Shenogen Pharma Group is not publicly available.
Can I buy Shenogen Pharma Group stock?
Shenogen Pharma Group shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shenogen Pharma Group's last funding round?
Shenogen Pharma Group's most recent funding round was Series E Extension on September 27, 2023.
Who are the main investors in Shenogen Pharma Group?
Key investors in Shenogen Pharma Group include Panlin Capital.
Will Shenogen Pharma Group IPO soon?
No public IPO plans have been announced for Shenogen Pharma Group.
How can I track Shenogen Pharma Group secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shenogen Pharma Group's secondary market activity and sign up for updates.